Potential strategies of the pharmaceutical and biotechnological firms in the Post-TRIPS scenario in India
dc.contributor.advisor | Basant, Rakesh | |
dc.contributor.author | Banerjee, Ajitabh | |
dc.contributor.author | Bhatia, Darshan | |
dc.date.accessioned | 2018-07-05T10:49:36Z | |
dc.date.available | 2018-07-05T10:49:36Z | |
dc.date.copyright | 2004 | |
dc.date.issued | 2004 | |
dc.identifier.uri | http://hdl.handle.net/11718/20863 | |
dc.language.iso | en | en_US |
dc.publisher | Indian Institute of Management Ahmedabad | en_US |
dc.relation.ispartofseries | SP;001090 | |
dc.subject | Potential strategies | en_US |
dc.subject | Pharmaceutical and biotechnological firms | en_US |
dc.subject | Post-TRIPS scenario in India | en_US |
dc.title | Potential strategies of the pharmaceutical and biotechnological firms in the Post-TRIPS scenario in India | en_US |
dc.type | Student Project | en_US |
Files in this item
This item appears in the following Collection(s)
-
Student Projects [3208]
Student Projects